DOCN vs PATH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 10, 2026

DOCN

49.2
AI Score
VS
DOCN Wins

PATH

39.0
AI Score

Investment Advisor Scores

DOCN

49score
Recommendation
HOLD

PATH

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCN PATH Winner
Forward P/E 97.0874 16.0514 PATH
PEG Ratio 1.5379 0.4586 PATH
Revenue Growth 28.6% 17.3% DOCN
Earnings Growth -24.5% 105.7% PATH
Tradestie Score 49.2/100 39.0/100 DOCN
Profit Margin 23.3% 19.6% DOCN
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL DOCN

Relative Price Performance (Last 90 Days)

DOCN 1M: -11.8% · 3M: -27.0% PATH 1M: +60.7% · 3M: +55.1%

Current Technical Phase

DOCN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 42

RSI (14): 42.4 · Price: $115.64

PATH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.5% over 20 days), RSI 70

RSI (14): 69.7 · Price: $16.39

Fundamentals Snapshot

Metric DOCN PATH
Market Cap
Forward P/E 62.5 20.9
Trailing P/E 52.9 25.9
Revenue (TTM)
Revenue Growth 0.3% 0.2%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% 0.1%
EPS 2.16 0.61
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DOCN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.